查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1785739

全球人工角膜植入市場

Artificial Corneal Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球人工角膜植入市場規模將達1.209億美元

全球人工角膜植入市場規模預計在2024年為8,280萬美元，預計到2030年將達到1.209億美元，在2024-2030年的分析期內，複合年成長率為6.5%。硬性人工角膜是本報告分析的細分市場之一，預計其複合年成長率為5.7%，到分析期結束時規模將達到6570萬美元。軟性人工角膜市場在分析期間的複合年成長率預計為7.5%。

美國市場規模估計為 2,180 萬美元，中國市場預計複合年成長率為 6.4%

美國人工角膜植入市場規模預計2024年達到2,180萬美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到1,950萬美元，2024年至2030年的複合年成長率為6.4%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為5.9%和5.6%。在歐洲，預計德國的複合年成長率為5.3%。

全球人工角膜植入市場－主要趨勢與促進因素摘要

人工角膜植入如何解決視力喪失問題？

人工角膜植入徹底改變了角膜失明和角膜損傷的治療格局，為無法接受傳統角膜移植的患者提供了新的治療選擇。圓錐角膜、角膜瘢痕和營養不良等疾病使這些植入成為恢復視力的重要解決方案。生物相容性材料和手術技術的進步提高了這些植入的整合性，並降低了排斥風險。角膜疾病盛行率的上升以及全球角膜捐贈短缺，刺激了人們對人工植入的需求，使其成為可靠且方便的選擇。

科技進步在改善治療結果方面發揮什麼作用？

人工角膜植入市場正經歷快速的技術創新，其重點在於提高耐用性、生物相容性和手術便利性。水凝膠和奈米複合材料等先進材料能夠模擬天然角膜的特性，從而提高光學清晰度並減少併發症。 3D列印技術正被用於製造患者專屬的植入，從而提高精準度和治療效果。微創手術技術也應運而生，縮短了病患恢復時間，使資源匱乏地區的病患更容易獲得手術。這些技術進步使人工角膜植入成為現代眼科的基石。

為什麼可訪問性是市場成長的關鍵？

可近性是推動人工角膜植入普及的主要因素，尤其是在角膜失明負擔最高的開發中國家。非政府組織和醫療保健系統正在投資宣傳宣傳活動並津貼治療補貼，以縮小可及性差距。此外，經濟實惠的植入的出現也使醫療資源匱乏的地區也能獲得這些植入物。製造商、政府和醫療保健提供者之間的夥伴關係，確保這些改變人生的治療能夠惠及最需要的人。

是什麼推動了人工角膜植入市場的成長？

人工角膜植入市場的成長動力源於角膜疾病日益成長的盛行率以及全球角膜捐贈短缺。材料科學和3D列印技術的進步使得生產耐用且針對特定患者的植入成為可能，從而改善了手術效果。人口老化加劇以及隨之而來的視力喪失風險進一步推動了需求。消費者意識的提升以及政府促進眼部健康的措施正在擴大市場基礎。此外，微創手術技術的進步使角膜植入更容易獲得且價格更實惠，從而確保了該領域的持續成長。

部分

植入物類型（硬性人工角膜、軟性人工角膜）、植入類型（合成植入、生物合成植入）、適應症（圓錐角膜適應症、眼部燒傷適應症、眼部瘢痕性類天皰瘡（OCP）適應症、角膜基質營養不良適應症、Stevens-Johnson症候群（SJS）適應症、其他門診

受訪公司範例

  • AJL Ophthalmic SA
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP29231

Global Artificial Corneal Implants Market to Reach US$120.9 Million by 2030

The global market for Artificial Corneal Implants estimated at US$82.8 Million in the year 2024, is expected to reach US$120.9 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Hard Keratoprosthesis, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$65.7 Million by the end of the analysis period. Growth in the Soft Keratoprosthesis segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.8 Million While China is Forecast to Grow at 6.4% CAGR

The Artificial Corneal Implants market in the U.S. is estimated at US$21.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$19.5 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Artificial Corneal Implants Market - Key Trends & Drivers Summarized

How Are Artificial Corneal Implants Addressing Vision Loss?

Artificial corneal implants are transforming the treatment landscape for corneal blindness and damage, providing an alternative for patients who cannot undergo traditional corneal transplants. Conditions such as keratoconus, corneal scarring, and dystrophies have made these implants a critical solution for restoring vision. With advancements in biocompatible materials and surgical techniques, these implants offer improved integration and reduced risk of rejection. The rising prevalence of corneal diseases, coupled with a shortage of donor corneas globally, has fueled demand for artificial implants as a reliable and accessible option.

What Role Do Technological Advancements Play in Enhancing Outcomes?

The artificial corneal implant market is witnessing rapid innovation, with a focus on improving durability, biocompatibility, and surgical ease. Advanced materials such as hydrogels and nanocomposites mimic the natural cornea’s properties, ensuring better optical clarity and reduced complications. 3D printing technologies are being utilized to create patient-specific implants, enhancing precision and outcomes. Minimally invasive surgical techniques have also emerged, reducing recovery times and increasing accessibility for patients in low-resource settings. These technological strides have positioned artificial corneal implants as a cornerstone of modern ophthalmology.

Why Is Accessibility a Key Focus for Market Growth?

Accessibility is a major factor driving the adoption of artificial corneal implants, especially in developing countries where the burden of corneal blindness is highest. Non-governmental organizations and healthcare systems are investing in awareness campaigns and subsidized treatments to bridge the accessibility gap. Additionally, the emergence of cost-effective implant options has expanded availability in underserved regions. Partnerships between manufacturers, governments, and healthcare providers are ensuring that these life-changing treatments reach the people who need them most.

What Drives the Growth of the Artificial Corneal Implants Market?

The growth in the artificial corneal implants market is driven by an increasing prevalence of corneal diseases and a global shortage of donor corneas. Advancements in materials science and 3D printing have enabled the production of highly durable and patient-specific implants, improving surgical outcomes. The rise in geriatric populations and the associated risk of vision loss further boosts demand. Consumer awareness and government initiatives promoting eye health are expanding the market’s reach. Moreover, technological breakthroughs in minimally invasive procedures are making corneal implants more accessible and affordable, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Artificial Corneal Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Transplant Type (Hard Keratoprosthesis, Soft Keratoprosthesis); Implant Type (Synthetic Implant, Biosynthetic Implant); Indication (Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid (OCP) Indication, Corneal Stromal Dystrophies Indication, Stevens-Johnson Syndrome (SJS) Indication, Other Indications); End-Use (Hospitals End-Use, Ophthalmic Centers End-Use, Ambulatory Surgical Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AJL Ophthalmic S.A.
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Corneal Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Corneal Blindness and Vision Disorders Driving Demand
    • Increasing Success Rates of Synthetic and Bioengineered Corneal Implants
    • Advancements in Stem Cell Therapy for Corneal Regeneration Supporting Growth
    • Growing Adoption of 3D Bioprinting Technology in Artificial Corneal Implants
    • Expansion of Minimally Invasive Corneal Implantation Techniques
    • Increasing Collaborations Between Ophthalmic Research Institutes and Manufacturers
    • Rising Geriatric Population Driving Demand for Vision Restoration Solutions
    • Advancements in Biocompatible and Long-Lasting Implant Materials
    • Expanding Access to Corneal Transplant Alternatives in Developing Countries
    • Growing Use of AI and Robotics in Corneal Implantation Surgeries
    • Surge in FDA and Regulatory Approvals for Next-Generation Implants
    • Rising Private and Government Investments in Ophthalmic Healthcare
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Corneal Implants Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hard Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hard Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Soft Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Soft Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Keratoconus Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Keratoconus Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Ocular Burns Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Ocular Burns Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ocular Cicatricial Pemphigoid Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Ocular Cicatricial Pemphigoid Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Corneal Stromal Dystrophies Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Corneal Stromal Dystrophies Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stevens-Johnson Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stevens-Johnson Syndrome Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Ophthalmic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Ophthalmic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Synthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Synthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Biosynthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Biosynthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • JAPAN
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • CHINA
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • EUROPE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • FRANCE
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • GERMANY
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030

IV. COMPETITION